NLRP3 and prostate carcinoma: Based on the PCa tissue sequencing of the next generation of Chinese population, further explore the PCa tumor-associated inflammatory bodies, study their molecular characteristics and functional mechanisms, and discover the NLRP3 molecule for the early diagnosis of PCa, which is helpful to better understand the biological behavior of PCa cells and find new targets for the treatment of prostate cancer.